Nobiletin Inhibits CD36-Dependent Tumor Angiogenesis, Migration, Invasion, and Sphere Formation Through the Cd36/Stat3/Nf-Κb Signaling Axis

Nobiletin bioactivation in MDA-MB-468 breast cancer cells by cytochrome P450 CYP1 enzymes

(2018) Somchaiya Surichan et al.   FOOD AND CHEMICAL TOXICOLOGY

Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis

(2018) Andras Ladanyi et al.   ONCOGENE

Nobiletin Inhibits Angiogenesis by Regulating Src/FAK/STAT3-Mediated Signaling through PXN in ER+ Breast Cancer Cells

(2017) Nipin Sp et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Momilactone B Inhibits Ketosis In Vitro by Regulating the ANGPTL3-LPL Pathway and Inhibiting HMGCS2

(2016) Dong Young Kang et al.   ANIMAL BIOTECHNOLOGY

Targeting metastasis-initiating cells through the fatty acid receptor CD36

(2016) Gloria Pascual et al.   NATURE

The combination of methylsulfonylmethane and tamoxifen inhibits the Jak2/STAT5b pathway and synergistically inhibits tumor growth and metastasis in ER-positive breast cancer xenografts

(2015) Nipin SP et al.   BMC CANCER

Nobiletin inhibits invasion and migration of human nasopharyngeal carcinoma cell lines by involving ERK1/2 and transcriptional inhibition of MMP-2

(2015) Su-Yu Chien et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Long-chain acyl-CoA synthetase in fatty acid metabolism involved in liver and other diseases: An update

(2015) Sheng Yan   WORLD JOURNAL OF GASTROENTEROLOGY

Tumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugs

(2015) Che-Hsin Lee et al.   Oncotarget

Nobiletin enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cancer cells

(2015) Wenzhe Ma et al.   Scientific Reports

Circadian Control of Fatty Acid Elongation by SIRT1 Protein-mediated Deacetylation of Acetyl-coenzyme A Synthetase 1

(2014) Saurabh Sahar et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Activation of ATP Citrate Lyase by mTOR Signal Induces Disturbed Lipid Metabolism in Hepatitis B Virus Pre-S2 Mutant Tumorigenesis

(2014) Chiao-Fang Teng et al.   JOURNAL OF VIROLOGY

Tackling the cancer stem cells — what challenges do they pose?

(2014) Diwakar R. Pattabiraman et al.   NATURE REVIEWS DRUG DISCOVERY

The thrombospondin-1 receptor CD36 is an important mediator of ovarian angiogenesis and folliculogenesis

(2014) Kata Osz et al.   Reproductive Biology and Endocrinology

Thrombospondin-1 modulates VEGF signaling via CD36 by recruiting SHP-1 to VEGFR2 complex in microvascular endothelial cells

(2013) L.-Y. Chu et al.   BLOOD

Overexpressing TNF-Alpha in Pancreatic Ductal Adenocarcinoma Cells and Fibroblasts Modifies Cell Survival and Reduces Fatty Acid Synthesis via Downregulation of Sterol Regulatory Element Binding Protein-1 and Activation of Acetyl CoA Carboxylase

(2013) Mazhar Al-Zoubi et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Nobiletin attenuates metastasis via both ERK and PI3K/Akt pathways in HGF-treated liver cancer HepG2 cells

(2013) Ming-Der Shi et al.   PHYTOMEDICINE

NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer

(2013) Yihui Fan et al.   Protein & Cell

Mechanisms of Unphosphorylated STAT3 Transcription Factor Binding to DNA

(2012) Olga A. Timofeeva et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Fatty acid synthase and liver triglyceride metabolism: Housekeeper or messenger?

(2011) Anne P.L. Jensen-Urstad et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Nobiletin metabolites: Synthesis and inhibitory activity against matrix metalloproteinase-9 production

(2011) Tetsuta Oshitari et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Radioprotection in Normal Tissue and Delayed Tumor Growth by Blockade of CD47 Signaling

(2009) J. B. Maxhimer et al.   Science Translational Medicine

Thrombospondin and Apoptosis: Molecular Mechanisms and Use for Design of Complementation Treatments

(2008) Y. Mirochnik et al.   CURRENT DRUG TARGETS

Nobiletin, a citrus flavonoid with neurotrophic action, augments protein kinase A-mediated phosphorylation of the AMPA receptor subunit, GluR1, and the postsynaptic receptor response to glutamate in murine hippocampus

(2007) Kentaro Matsuzaki et al.   EUROPEAN JOURNAL OF PHARMACOLOGY